In an effort to secure medical supply chains and invest in the cures and treatment of the future, members of the House Ways and Means committee this week reintroduced major legislation that "ensures a healthier future for all Americans." BIO released the following statement:  "Small and emerging biotech companies are drivers of innovation across the country. As has been made abundantly clear throughout this pandemic, the scientists and researchers within this community work tirelessly to find solutions to the world’s most complex challenges. These companies, oftentimes with little capital to spare, are responsible for developing the lion’s share of breakthrough therapies and treatments, as well as other critical environmental and climate solutions.  "Thanks in part to the contributions of small and emerging biotech companies, America is an innovation powerhouse. Our nation produces more new therapies than the rest of the world combined, as just one example. "The “secret” to this success is really no secret at all; America has built an ecosystem that supports biotech companies of all sizes. This, along with our country’s world-class research institutes, helps sustain investment in critical research and development and allows scientists to bring breakthrough therapies and products to people around the world.  "A Ways & Means package led by Health Subcommittee Ranking Member Vern Buchanan, Rep. Brad Wenstrup, DPM, Rep. Drew Ferguson, DDS, and Rep. Mike Kelly is a critical building block for future biotech innovation. By providing much-needed incentives for research, development, novel manufacturing, and more, it will allow biotech companies -- especially small startups – to do what they do best: solve the world’s most complex scientific challenges. "BIO, representing hundreds of biotech companies, looks forward to working with lawmakers on this important legislative package."